MapLight Therapeutics, Inc. (MLPT) is drawing attention this week after a fresh Form 4 filing showed insider entity Catalyst4, Inc. purchasing 1,000,000 shares of the company on the open market on July 30, 2026. The purchase price came to $13.00 per share, for a total outlay of $13,000,000.00 — money spent directly by the insider, not part of an option exercise or equity grant.
Following the transaction, Catalyst4, Inc. holds 20,906,689 shares indirectly, through a trust or affiliated entity structure, according to the filing.
Part of a Broader Buying Pattern
This isn’t an isolated trade. SEC records show four separate open-market purchases of MLPT stock between July 28 and July 30, 2026, with a combined value of $15,314,794. The July 30 purchase detailed above accounts for the large majority of that total, meaning Catalyst4, Inc. and any related buyers stepped up their commitment to the stock across a tight three-day window rather than making a single one-off buy.
Whoisbuyingnow.com classifies this activity as a cluster buy — a designation reserved for situations where multiple insider purchases occur in close succession, often signaling coordinated conviction rather than routine portfolio activity. Cluster buys are watched closely by market observers because academic research on insider trading patterns has found that clustered buying, as a group phenomenon, has historically correlated with periods of subsequent stock outperformance more reliably than isolated single-insider purchases.
What the Filing Does and Doesn’t Tell Us
The Form 4 discloses the mechanics of the trade — shares, price, date, and resulting ownership stake — but it does not explain the insider’s rationale, and none is inferred here. Indirect ownership through a trust or entity structure is common for insiders who hold stakes on behalf of funds, family trusts, or other affiliated vehicles, and the filing does not specify which arrangement applies in this case.
MapLight Therapeutics has not issued a public statement tied to this specific filing as of publication. Readers tracking insider activity around MLPT can expect further disclosures if the buying pattern continues, given the pace of purchases logged over the past several days.
This article is based solely on information disclosed in a public SEC Form 4 filing and is intended for informational purposes. It does not constitute investment advice or a recommendation to buy or sell any security.
→ See all MLPT coverage on WhoIsBuyingNow
Source: original SEC Form 4 filing.